Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Duke University
- Study ID
- NCT05120635
- Status
- Recruiting
Conditions
- Emotional Memory
- Fear
- GAD
- PTSD
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- Deep Brain Stimulation — DEVICEDeep brain stimulation will be used
- Virtual and augmented reality tasks — BEHAVIORALVirtual and augmented reality tasks will be used.
Study Details
Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.
Key Dates
- Start date
- Oct 1, 2021
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Other: EMU ParticipantsSubjects participating in the study at the Epilepsy Monitoring Unity (EMU).
- Other: RNS ParticipantsSubjects with RNS implants.
Primary Outcome Measure
Physiological change - eye-blinks [ Time Frame: during the intervention/behavioral tasks with and without stimulation ]
Central Contacts
- Gabriela Vilchez9196812577
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Los Angeles | Los Angeles | California | 90024 | |
| Duke University Health System | Durham | North Carolina | 27705 | Nanthia Suthana, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Opioids and Social Support Enhanced Extinction EffectsEARLY_PHASE1 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)PHASE2 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama